Principia Wealth Advisory’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$746 Sell
7
-2
-22% -$242 ﹤0.01% 816
2026
Q1
$1.47K Sell
9
-3
-25% -$461 ﹤0.01% 599
2025
Q4
$2.09K Buy
12
+4
+50% +$730 ﹤0.01% 452
2025
Q3
$1.15K Buy
8
+5
+167% +$613 ﹤0.01% 597
2025
Q2
$302 Sell
3
-1
-25% -$76 ﹤0.01% 849
2025
Q1
$270 Sell
4
-1
-20% -$76 ﹤0.01% 720
2024
Q4
$345 Buy
+5
New +$360 ﹤0.01% 646

Other funds holding INSM

Principia Wealth Advisory's INSM Position: Q2 2026 in Review

Principia Wealth Advisory reduced its Insmed (INSM) stake by 22% in Q2 2026, selling an estimated $242 and leaving 7 shares worth $746. The position accounts for ﹤0.01% of the portfolio, ranked #816.

Principia Wealth Advisory first reported a position in INSM in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.09K in Q4 2025. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Principia Wealth Advisory held 7 shares of Insmed worth $746 as of Q2 2026.
  • Principia Wealth Advisory sold 2 Insmed shares in Q2 2026, an estimated $242.
  • Insmed made up ﹤0.01% of Principia Wealth Advisory's portfolio in Q2 2026, its #816 holding.
  • Principia Wealth Advisory first reported a position in Insmed in Q4 2024 and has held it in 7 quarters since.
  • Principia Wealth Advisory's Insmed position peaked at $2.09K in Q4 2025.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Principia Wealth Advisory's 13F filing for Q2 2026, filed 26 Aug 2026.